Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNuminus Wellness Inc

Numinus Wellness Inc

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
0.05 CAD 0.00(0%)
Last update at 2026-04-22T13:30:00Z
Market Cap
16.03M

Momentum Score

…

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.05
Low
0.05
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
6.49M
Revenue Per Share
0.02
Gross Profit TTM
2.69M
Debt / Equity
0.19
ROE
-858.14%
Net Debt
-25.19M
ROCE
-669.36%
Diluted EPS TTM
-0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Income before tax -14.60M -30.26M -44.92M -18.77M -9.60M
Net income -19.64M -30.26M -44.88M -21.56M -11.86M
Selling general administrative 11.57M 32.52M 25.17M 11.69M 6.01M
Selling and marketing expenses 0.77M - 2.19M 2.22M 0.91M
Gross profit 1.17M 8.37M 1.78M -0.08M 0.09M
Reconciled depreciation 0.56M 2.83M 1.51M 0.72M 0.61M
Ebit -14.50M - -28.00M -15.88M -7.27M
Ebitda -13.94M - -26.50M -15.16M -6.59M
Depreciation and amortization 0.56M - 1.51M 0.72M 0.68M
Operating income -11.71M -26.96M -28.00M -15.88M -7.27M
Other operating expenses 15.88M - 34.94M 17.35M 8.15M
Interest expense 0.10M 0.76M 0.56M 0.11M 0.14M
Tax provision - 0.00M -0.03M 0.00M -0.01M
Interest income 0.01M 0.01M 0.35M 0.11M 0.13M
Net interest income -0.09M -0.75M -0.56M -0.11M -0.13M
Extraordinary items -5.04M - - - -
Income tax expense - - -0.03M 2.78M 2.26M
Total revenue 4.17M 23.18M 6.49M 1.51M 0.88M
Total operating expenses 12.87M 50.14M 30.23M 15.76M 7.36M
Cost of revenue 3.00M 14.81M 4.72M 1.60M 0.79M
Total other income expense net -2.89M -2.55M -16.91M -2.90M -2.33M
Net income from continuing ops -14.60M -30.26M -44.88M -18.77M -9.60M
Net income applicable to common shares -19.64M - -44.88M -18.77M -9.60M
Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Total assets 10.77M 24.33M 52.63M 64.14M 5.12M
Intangible assets - - 0.34M - -
Other current assets - - - 0.00M 0.09M
Total liab 10.05M 10.28M 11.42M 3.31M 2.32M
Total stockholder equity 0.73M 14.05M 41.21M 60.83M 2.80M
Other current liab 5.79M - 0.20M 0.15M 0.17M
Common stock - - 109.20M 88.87M 18.94M
Capital stock 117.42M 112.27M 109.20M 88.87M 18.94M
Retained earnings -136.51M -116.87M -86.61M -41.73M -22.95M
Other liab - - 0.43M 0.20M -
Good will - 0.00M 2.17M - -
Other assets - - 0.24M 0.02M 0.01M
Cash 1.96M 8.58M 33.04M 59.29M 1.63M
Total current liabilities 8.61M 4.64M 4.58M 1.91M 2.01M
Current deferred revenue - - 0.24M 0.05M -
Net debt - - -25.19M -57.69M -1.21M
Short term debt - - 1.44M 0.40M 0.11M
Short long term debt 0.05M 0.07M 0.06M - -
Short long term debt total - - 7.85M 1.60M 0.42M
Other stockholder equity - - 1.09M 0.50M 6.82M
Property plant equipment - - 11.38M 3.15M 2.44M
Total current assets 9.80M 12.05M 36.12M 60.97M 2.67M
Long term investments 0.00M 2.08M 2.37M - -
Net tangible assets - - 38.70M 60.83M 2.80M
Short term investments - - - 0.00M 0.01M
Net receivables 0.76M 1.77M 1.60M 0.52M 0.54M
Long term debt 0.15M 0.16M 0.21M 0.00M 0.04M
Inventory - - 0.00M 0.00M 0.00M
Accounts payable 1.29M 2.89M 2.71M 1.30M 1.73M
Accumulated other comprehensive income - - 17.54M 13.19M 6.82M
Non currrent assets other - - 0.24M 0.02M 0.01M
Non current assets total 0.97M 12.28M 16.51M 3.17M 2.45M
Capital lease obligations 1.83M 6.96M 7.57M 1.60M 0.38M
Long term debt total - - 6.41M 1.20M 0.32M
Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Investments 0.86M -0.37M 0.12M 0.01M 0.01M
Change to liabilities - - -0.00M -0.61M 0.20M
Total cashflows from investing activities 0.86M - 0.12M -0.74M -0.13M
Net borrowings -0.56M - -0.68M -0.33M 0.16M
Total cash from financing activities 4.54M -1.46M 0.01M 73.98M 7.02M
Change to operating activities - - -0.36M -1.23M -0.54M
Net income -19.64M -30.26M -44.88M -18.77M -9.60M
Change in cash -6.62M -24.46M -26.25M 57.67M 1.54M
Begin period cash flow 8.58M 33.04M 59.29M 1.63M 0.09M
End period cash flow 1.96M 8.58M 33.04M 59.29M 1.63M
Total cash from operating activities -12.43M -22.76M -26.23M -15.58M -5.36M
Issuance of capital stock 5.31M - 0.00M 57.15M 6.13M
Depreciation 0.56M 2.83M 1.51M 0.72M 0.61M
Other cashflows from investing activities 0.03M - 1.37M -0.10M -0.16M
Change to inventory - - 0.00M -0.00M 0.00M
Change to account receivables 0.30M -1.32M 0.10M -0.13M -0.17M
Sale purchase of stock 5.31M - 0.69M 74.32M 6.75M
Other cashflows from financing activities -0.20M - 0.69M 17.17M 1.29M
Change to netincome - - 17.41M 4.45M 4.14M
Capital expenditures 0.03M 0.38M 1.25M 0.64M 0.04M
Change in working capital 0.89M -1.07M -0.26M -1.97M -0.51M
Stock based compensation 0.56M 1.87M 3.45M 1.82M 1.88M
Other non cash items 5.19M 0.12M 13.99M 2.63M 2.26M
Free cash flow -17.50M -23.14M -27.48M -16.22M -5.39M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NUMI
Numinus Wellness Inc		 -
-%		 0.05 - - 2.47 1.59 0.68 -1.37
EXE
Extendicare Inc		 -0.53
1.87%		 27.76 25.21 23.92 1.59 7.26 1.62 14.43
SIA
Sienna Senior Living Inc		 0.19
0.94%		 20.42 45.94 38.17 2.23 3.17 3.57 21.90
WELL
WELL Health Technologies Corp		 0.06
1.33%		 4.20 - 13.87 0.80 1.23 1.09 9.83
DR
Medical Facilities Corporation		 -0.01
0.07%		 15.03 15.57 12.94 1.18 2.87 0.92 3.64

Profile*

Numinus Wellness Inc

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. is headquartered in Vancouver, Canada.

250 - 997 Seymour Street, Vancouver, BC, Canada, V6B 3M1

236 439 3098

https://www.numinusnetwork.com

Name Title Year Born
Mr. Payton Nyquvest Co-Founder, CEO & Chairman NA
Mr. Michael Tan M.B.A. Pres, COO & Director NA
Mr. John Fong CPA, CGA CFO & Corp. Sec. NA
Dr. Evan Wood M.D., Ph.D. Chief Medical Officer NA
Dr. Paul Thielking M.D. Chief Science Officer NA
Jamie Kokoska VP of Investor Relations NA
Mr. Ian Noble Chief Communications Officer NA
Ms. Julie Saunders Chief Marketing Officer NA
Ms. Judy Varga M.Sc. Head of Laboratory Operations NA
Dr. Reid J. Robison M.D., MBA Chief Clinical Officer 1977

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…